gallic acid has been researched along with Cancer of Liver in 19 studies
gallate : A trihydroxybenzoate that is the conjugate base of gallic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Thus, in order to better comprehend the mechanism by which polyphenols regulate hTERT, the present study investigated the effects of the natural polyphenols Resveratrol, Gallic acid, and Kuromanin chloride on hTERT, Nrf2, and SIRT1 expression as well as oxidative stress in HepG2 hepatocellular carcinoma." | 8.31 | The effect of natural polyphenols Resveratrol, Gallic acid, and Kuromanin chloride on human telomerase reverse transcriptase (hTERT) expression in HepG2 hepatocellular carcinoma: role of SIRT1/Nrf2 signaling pathway and oxidative stress. ( Azadbakht, O; Behrouj, H; Ghojoghi, R; Moghadam, D; Sabaghan, M; Vakili, S; Veisi, A; Zarei, R; Zarezade, V, 2023) |
| "Nonalcoholic fatty liver disease (NAFLD) usually includes NAFL called simple hepatosteatosis and nonalcoholic steatohepatitis (NASH) called more steatohepatitis." | 5.91 | Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function. ( Liu, Z; Wang, E; Wang, J; Yang, L; Zhang, J; Zhang, W; Zhao, W, 2023) |
| "The global burden of hepatocellular carcinoma is increasing; actually, it is estimated as 750,000 new cases annually." | 5.46 | Gallic acid against hepatocellular carcinoma: An integrated scheme of the potential mechanisms of action from in vivo study. ( Aglan, HA; Ahmed, HH; El-Toumy, SA; Mahmoud, NS, 2017) |
| " Thus, in order to better comprehend the mechanism by which polyphenols regulate hTERT, the present study investigated the effects of the natural polyphenols Resveratrol, Gallic acid, and Kuromanin chloride on hTERT, Nrf2, and SIRT1 expression as well as oxidative stress in HepG2 hepatocellular carcinoma." | 4.31 | The effect of natural polyphenols Resveratrol, Gallic acid, and Kuromanin chloride on human telomerase reverse transcriptase (hTERT) expression in HepG2 hepatocellular carcinoma: role of SIRT1/Nrf2 signaling pathway and oxidative stress. ( Azadbakht, O; Behrouj, H; Ghojoghi, R; Moghadam, D; Sabaghan, M; Vakili, S; Veisi, A; Zarei, R; Zarezade, V, 2023) |
| "encapsulated GA-NC (gallic acid nanocomposite) in normal and hepatocellular carcinoma (HCC)-induced rats." | 3.88 | Improving Anti-Cancer Potentiality and Bioavailability of Gallic Acid by Designing Polymeric Nanocomposite Formulation ( Abd-Rabou, AA; Ahmed, HH; Galal, AF; Mehaya, FM; Shalby, AB, 2018) |
| "Nonalcoholic fatty liver disease (NAFLD) usually includes NAFL called simple hepatosteatosis and nonalcoholic steatohepatitis (NASH) called more steatohepatitis." | 1.91 | Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function. ( Liu, Z; Wang, E; Wang, J; Yang, L; Zhang, J; Zhang, W; Zhao, W, 2023) |
| "Syringic acid (SA) has been studied for its hepatoprotective, anti-inflammatory, immunomodulatory, free radical scavenging, and antioxidant activities." | 1.51 | Syringic acid triggers reactive oxygen species-mediated cytotoxicity in HepG2 cells. ( Ezhilarasan, D; Gheena, S, 2019) |
| "The global burden of hepatocellular carcinoma is increasing; actually, it is estimated as 750,000 new cases annually." | 1.46 | Gallic acid against hepatocellular carcinoma: An integrated scheme of the potential mechanisms of action from in vivo study. ( Aglan, HA; Ahmed, HH; El-Toumy, SA; Mahmoud, NS, 2017) |
| "Gallic acid was identified and quantified in EP extract and active fractions, EP." | 1.43 | Pro-apoptotic and cytotoxic effects of enriched fraction of Elytranthe parasitica (L.) Danser against HepG2 Hepatocellular carcinoma. ( Aranjani, JM; Biswas, S; Kumar, N; Lobo, R; Mathew, AE; Mathew, JE; Nandakumar, K; Varghese, S, 2016) |
| "The mechanism of human hepatoma BEL-7404 cells apoptosis induced by Galic acid from leaves of Phyllanthus emblica may be blocking G2/M period in cell life cycle, up-regulating the expression of Bax and down-regulating the expression of Bcl-2, that can decrease membrane potential of mitochondria,and triggered the caspases of activation of cascade and induced cell death." | 1.37 | [Study of galic acid extracted from the leaves of Phyllanthus emblica on apoptotic mechanism of human hepatocellular carcinoma cells BEL-7404]. ( Huang, JL; Zhong, ZG, 2011) |
| "In the present study, the human hepatoma cell line, HepG2, was used as a model to investigate the effect of antioxidant phenolic acids on enzymatic activity and expression of one of the major phase II sulfate conjugation enzymes, P-form phenolsulfotransferase (PST-P)." | 1.33 | Induction of phenolsulfotransferase expression by phenolic acids in human hepatoma HepG2 cells. ( Huang, SM; Yeh, CT; Yen, GC, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 5 (26.32) | 2.80 |
| Authors | Studies |
|---|---|
| Jurič, A | 1 |
| Huđek Turković, A | 1 |
| Brčić Karačonji, I | 1 |
| Prđun, S | 1 |
| Bubalo, D | 1 |
| Durgo, K | 1 |
| Moghadam, D | 1 |
| Zarei, R | 1 |
| Vakili, S | 1 |
| Ghojoghi, R | 1 |
| Zarezade, V | 1 |
| Veisi, A | 1 |
| Sabaghan, M | 1 |
| Azadbakht, O | 1 |
| Behrouj, H | 1 |
| Zhang, J | 2 |
| Zhang, W | 1 |
| Yang, L | 1 |
| Zhao, W | 1 |
| Liu, Z | 1 |
| Wang, E | 1 |
| Wang, J | 1 |
| Chen, C | 1 |
| Zhang, S | 1 |
| Zhang, R | 1 |
| Sun, P | 1 |
| Shi, C | 1 |
| Abdalla, M | 1 |
| Li, A | 1 |
| Xu, J | 1 |
| Du, W | 1 |
| Liu, Y | 1 |
| Tang, C | 1 |
| Yang, Z | 1 |
| Jiang, X | 1 |
| Huang, CY | 1 |
| Chang, YJ | 1 |
| Wei, PL | 1 |
| Hung, CS | 1 |
| Wang, W | 1 |
| Aglan, HA | 1 |
| Ahmed, HH | 2 |
| El-Toumy, SA | 1 |
| Mahmoud, NS | 1 |
| Galal, AF | 1 |
| Shalby, AB | 1 |
| Abd-Rabou, AA | 1 |
| Mehaya, FM | 1 |
| Gheena, S | 1 |
| Ezhilarasan, D | 1 |
| Kumar, N | 1 |
| Biswas, S | 1 |
| Mathew, AE | 1 |
| Varghese, S | 1 |
| Mathew, JE | 1 |
| Nandakumar, K | 1 |
| Aranjani, JM | 1 |
| Lobo, R | 1 |
| Zhong, ZG | 2 |
| Huang, JL | 2 |
| Liang, H | 1 |
| Zhong, YN | 1 |
| Zhang, WY | 1 |
| Wu, DP | 1 |
| Zeng, CL | 1 |
| Wang, JS | 1 |
| Wei, YH | 1 |
| Dauer, A | 1 |
| Hensel, A | 1 |
| Lhoste, E | 1 |
| Knasmüller, S | 1 |
| Mersch-Sundermann, V | 1 |
| Yeh, CT | 1 |
| Huang, SM | 1 |
| Yen, GC | 1 |
| Zong, L | 1 |
| Inoue, M | 2 |
| Nose, M | 1 |
| Kojima, K | 1 |
| Sakaguchi, N | 1 |
| Isuzugawa, K | 2 |
| Takeda, T | 1 |
| Ogihara, Y | 2 |
| Kim, JA | 1 |
| Kang, YS | 1 |
| Lee, SH | 1 |
| Lee, EH | 1 |
| Yoo, BH | 1 |
| Lee, YS | 1 |
| Gong, G | 1 |
| Waris, G | 1 |
| Tanveer, R | 1 |
| Siddiqui, A | 1 |
| Krüger, B | 1 |
| Nasemann, T | 1 |
| Semenova, LP | 1 |
| Nikol'skaia, TA | 1 |
| Emanuel', NM | 1 |
19 other studies available for gallic acid and Cancer of Liver
| Article | Year |
|---|---|
Cytotoxic activity of strawberry tree (
Topics: Antineoplastic Agents; Antioxidants; Biphenyl Compounds; Caco-2 Cells; Carcinoma, Hepatocellular; Ca | 2022 |
The effect of natural polyphenols Resveratrol, Gallic acid, and Kuromanin chloride on human telomerase reverse transcriptase (hTERT) expression in HepG2 hepatocellular carcinoma: role of SIRT1/Nrf2 signaling pathway and oxidative stress.
Topics: Carcinoma, Hepatocellular; Chlorides; Gallic Acid; Humans; Liver Neoplasms; NF-E2-Related Factor 2; | 2023 |
Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function.
Topics: AMP-Activated Protein Kinases; Animals; Carcinoma, Hepatocellular; Gallic Acid; Humans; Lipid Metabo | 2023 |
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; | 2020 |
Methyl gallate, gallic acid-derived compound, inhibit cell proliferation through increasing ROS production and apoptosis in hepatocellular carcinoma cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Carcinoma, Hepatocell | 2021 |
Gallic acid against hepatocellular carcinoma: An integrated scheme of the potential mechanisms of action from in vivo study.
Topics: alpha-Fetoproteins; Animals; Apoptosis; Biomarkers, Tumor; Carcinoma, Hepatocellular; Diethylnitrosa | 2017 |
Improving Anti-Cancer Potentiality and Bioavailability of Gallic Acid by Designing Polymeric Nanocomposite Formulation
Topics: Animals; Biological Availability; Carcinoma, Hepatocellular; Diethylnitrosamine; Drug Compounding; F | 2018 |
Syringic acid triggers reactive oxygen species-mediated cytotoxicity in HepG2 cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Survival; Gallic Acid; Gene Ex | 2019 |
Pro-apoptotic and cytotoxic effects of enriched fraction of Elytranthe parasitica (L.) Danser against HepG2 Hepatocellular carcinoma.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Survival; Gallic Acid; | 2016 |
[The effect of gallic acid extracted from leaves of Phyllanthus emblica on apoptosis of human hepatocellular carcinoma BEL-7404 cells].
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Prol | 2009 |
[Study of galic acid extracted from the leaves of Phyllanthus emblica on apoptotic mechanism of human hepatocellular carcinoma cells BEL-7404].
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Carcino | 2011 |
Genotoxic and antigenotoxic effects of catechin and tannins from the bark of Hamamelis virginiana L. in metabolically competent, human hepatoma cells (Hep G2) using single cell gel electrophoresis.
Topics: Anthocyanins; Antineoplastic Agents, Phytogenic; Benzo(a)pyrene; Carcinoma, Hepatocellular; Catechin | 2003 |
Induction of phenolsulfotransferase expression by phenolic acids in human hepatoma HepG2 cells.
Topics: Arylsulfotransferase; Carcinoma, Hepatocellular; Cell Division; Enzyme Induction; Gallic Acid; Gene | 2005 |
Metabolic fate of gallic acid orally administered to rats.
Topics: Administration, Oral; Animals; Chromatography, High Pressure Liquid; Drug Administration Routes; Gal | 1999 |
Glibenclamide induces apoptosis through inhibition of cystic fibrosis transmembrane conductance regulator (CFTR) Cl(-) channels and intracellular Ca(2+) release in HepG2 human hepatoblastoma cells.
Topics: Apoptosis; Caco-2 Cells; Calcium; Chlorides; Cystic Fibrosis Transmembrane Conductance Regulator; Da | 1999 |
Different generation of inhibitors against gallic acid-induced apoptosis produces different sensitivity to gallic acid.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Chromatography, Gel; Culture Media, Condition | 2001 |
Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B.
Topics: Acetylcysteine; Antioxidants; Calcium; Calcium Signaling; Carcinoma, Hepatocellular; Chelating Agent | 2001 |
[Acanthosis nigricans in liver hamartoma and excessive increase of serum gallic acids: a hitherto undescribed combination].
Topics: Acanthosis Nigricans; Adolescent; Bilirubin; Biopsy; Cell Nucleus; Cytoplasmic Granules; Female; Gal | 1973 |
[Oxidation phosphorylation and respiration in liver mitochondria and solid hepatoma of mice suppressed by propylgallate].
Topics: Animals; Antioxidants; Carcinoma, Hepatocellular; Gallic Acid; Liver Neoplasms; Mice; Neoplasms, Exp | 1965 |